N-Hydroxysuccinimide, often known as NHS, didn’t simply pop up as a standard chemical tool; labs worldwide have leaned on it since the mid-20th century for peptide synthesis and bioconjugation. Its rise in prominence followed the development of carbodiimide chemistry, which revolutionized ways to attach dyes, labels, and drugs to proteins. Research groups across Europe and the United States found they could achieve more reliable results using NHS-activated esters. The demand for efficient peptide and protein modification pushed the chemical industry to refine its production, focusing on purity and yield. Through direct experience in the lab, I've watched synthetic and analytical teams time and again choose NHS because the chemistry works well, and the results remain consistent under varying protocols.
You can walk into any laboratory supply warehouse, and NHS powder lines the shelves alongside everyday amino acids and solvents. Manufacturers pack it for research and industrial use, never shying from labeling it a high-purity reagent. Its role as a coupling additive means research students, postdocs, and professional chemists reach for it almost daily; the molecule’s reliability matters when budgets and timelines run tight.
NHS comes as a colorless or off-white crystalline solid. It has a melting point hovering near 97–98°C and dissolves readily in polar organic solvents like DMF and DMSO. Unlike compounds that degrade on a shelf, NHS remains stable for months in a cool, dry environment—tackling the humidity with proper sealing works every time. Chemically, the succinimide ring activates the oxygen atom, which is why it transfers easily to carboxylic groups on proteins or polymers.
Nearly every supplier prints key details for NHS, including CAS Number 6066-82-6 and purity levels from 98% upwards. Labels show batch numbers, storage instructions, and hazard statements based on current GHS and REACH standards. Handling requires gloves and goggles, as accidental spills irritate the skin and eyes. Shelf-life regularly exceeds two years under proper storage. Labs that emphasize lot traceability and documentation rarely find fault with the standard labeling.
Industrial chemists produce NHS by reacting succinic anhydride with hydroxylamine under controlled conditions. They’ll use acetic anhydride and sodium acetate as catalysts, optimizing reaction temperature to favor product over side reactions. This synthesis route remains preferred due to high yield and few purification steps. Aqueous washes or recrystallization remove side products, and routine quality checks keep impurities low.
NHS finds its utility through activation of carboxyl groups. Combine it with a carbodiimide—say, EDC or DCC—and instantly, you get an NHS-ester ready to react with an amine. This workhorse reaction forms the backbone of peptide coupling, protein crosslinking, and biotinylation studies. In my own work, NHS-ester linkages made antibody labeling and drug-delivery modifications straightforward without unnecessary side-product headaches. By swapping out different carbodiimides or linking NHS to new carboxylic acids, scientists expand their toolkit for novel conjugates. This adaptability helps turn creative chemistry into routine protocol.
NHS may appear on order forms as N-hydroxysuccinimide, or less often as HOSu. You’ll spot related products from major brands under similar trade names; no matter the context, formulations generally refer to the plain reagent, without added solvents or stabilizers. The IUPAC name—1-hydroxy-2,5-pyrrolidinedione—shows up less, except on safety data sheets or patent literature.
Handling NHS means counting on basic lab safety: gloves, coats, goggles. Its dust irritates, so weighing under a fume hood keeps exposure low. This compound doesn’t pose the acute toxicity risks found in many organics, though it can inflame eyes and skin upon direct contact. On an operational level, handlers should wash splash-prone areas promptly and dispose of waste in keeping with municipal environmental rules. Chemical hygiene plans benefit from including NHS, and it helps when new staff receive a clear rundown on its hazards.
NHS-driven reactions find homes in biochemistry, molecular biology, materials science, and pharmaceutical development. Researchers couple peptides, tag antibodies, immobilize proteins, and fabricate responsive hydrogels using NHS chemistry. Diagnostic assay development and drug-conjugate formulation lean heavily on its quick, water-tolerant activation steps. In environmental testing, NHS labels contaminants for fluorescence analysis. The comfort and reproducibility of these protocols stand out when deadlines loom or project costs rise, making NHS a fixture across experimental biology.
Innovation thrives on familiar reagents like NHS. Recent years brought fresh approaches: scientists have tailored NHS-based linkers for click chemistry and responsive polymer systems, pushing applications into targeted drug delivery and tissue engineering. Product engineers work alongside pharmacologists to tune NHS derivatives that enable better-controlled release or site-specific labeling. Some university groups investigate biodegradable polymers that use NHS-ester chemistry to control hydrolysis rates, harnessing the same reliable reactivity in smarter frameworks.
On the toxicity front, NHS ranks well compared to harsher crosslinkers. Animal and in vitro assays reveal low acute and chronic toxic effects at the concentrations used in research. Eye irritation and mild skin inflammation dominate the concerns during mishandling; toxicity data indicate low systemic absorption from casual contact. By focusing on proper protective gear and ventilation, labs keep incidents rare and consequences minor. Broader environmental studies suggest NHS poses negligible ecological impact due to rapid degradation in water.
NHS chemistry isn’t fading. On the contrary, research spurs new products: NHS-activated drug carriers, engineered biointerfaces, and stimuli-responsive sensors. Startups and academic spin-offs seek out NHS-ester reactions in the race for personalized medical diagnostics. Advances in polymer conjugation and antibody-drug therapies often rely on tweaking existing NHS protocols to shorten timescales and cut costs. From years of handling this staple compound, its future looks set—not just as a standard toolkit component, but as a launchpad for cleaner and more precise molecular design.
N-Hydroxisuccinimide shows up on the labels of chemicals in research labs everywhere, though most people outside the world of science don’t hear its name. Known by its abbreviation NHS, this compound plays a key role in making connections between molecules. NHS stands out for helping researchers link proteins, peptides, or other molecules together, and this driving force pushes advances in medicine, diagnostics, and even modern agriculture.
I’ve run plenty of experiments that depend on sticking two molecules together at a specific site. NHS brings reliable results for these “coupling” tasks. Laboratory protocols rely on it to create stable reactions, mostly through what chemists call “esterification reactions.” The actual magic comes when NHS forms an active ester with carboxylic acids—turning a “carboxyl” group into a much more reactive partner. This active ester swiftly grabs hold of amines (common structures in proteins and drugs), binding the two parts with little fuss. In plain English: NHS acts as a matchmaker, snapping molecules together so they can do new jobs.
Think about COVID-19 rapid tests, routine blood checks, or targeted cancer therapies. Behind these advances, NHS quietly does heavy lifting. Medical device makers use NHS for surface modifications. Conjugating an antibody to a fluorescent dye with NHS lets imaging equipment pick out cancer cells in tissue. Bioengineering labs apply NHS to develop new drug delivery tools, where precise linking between molecules decides how well a therapy finds its target.
NHS also stands as a popular choice for preparing proteins in research or manufacturing. Companies use NHS in manufacturing vaccines and antibody drugs. It helps researchers control where modifications take place, which cuts down on mistakes and wasted time. Because labs and companies depend on repeatable results, they come back to NHS time and again. It’s tough to find a replacement that gives both speed and accuracy like this compound.
I’ve seen safety officers warn staff about NHS, since it’s not something to sprinkle around carelessly. Handling it means wearing gloves, goggles, and shielding from moisture—NHS reacts with water, often spoiling experiments. The material safety data sheet reads like a reminder of why proper storage and handling rules matter. Some workers suggest that companies should explore greener options, considering the push for sustainable chemistry. Right now, though, NHS brings reliability and cost control, two things that matter to both scientists and manufacturers. As labs update their green practices, researchers watch for alternatives, testing how other compounds perform without sacrificing accuracy.
One headache comes up when scaling NHS reactions from bench to factory. Fluctuations in humidity or temperature can spoil batches. Consistency and record-keeping become essential. This isn’t unique to NHS, but it’s a known challenge for anyone using this chemical in mass production.
The world of biomedical science keeps searching for new linkers that work better with less risk. NHS holds onto its spot because the results speak for themselves. From my time in labs, nothing frustrates researchers more than losing a day to a reaction that fizzled out. NHS tends to deliver. As technology moves forward, people in the industry hope for newer tools—maybe with fewer hazards and more “green” benefits—but NHS keeps showing up at the heart of scientific progress.
N-Hydroxy Succinimide, often called NHS, shows up in research labs for good reasons. With its key role in peptide synthesis and bioconjugation, researchers count on this chemical to help build the next wave of biotechnologies. Chemical reliability doesn’t last by accident. The storage routine makes or breaks the quality.
NHS breaks down in moist environments, losing its punch and leaving you with wasted time and cash. Nobody wants to open a bottle and find the compound clumped or yellowed. Moisture, heat, and light team up and ruin your batch. Just leaving the container open too long can drop the quality.
I’ve seen plenty of labs skip small steps. Somebody cracks a bottle open, leaves it by the centrifuge, then shrugs when results don’t add up. Dry conditions protect your reagents from that fate. A moisture-proof bottle, tightly capped, does more than keep things neat — it keeps your experiment viable.
NHS isn’t wildly expensive, but losing a reaction or needing a whole new synthesis will rack up costs fast. That happened once when a colleague took shortcuts, leaving NHS on a warm bench instead of the refrigerator. The next set of conjugations didn’t meet purity checks, and his whole batch of antibody conjugates went in the autoclave — straight to waste. The lab paid, twice: lost time, wasted resources.
Most published recommendations and manufacturers call for storing NHS at low temperatures, usually between 2°C and 8°C, below room temperature. My own experience echoes this advice. I keep mine in the refrigerator, inside a sealed container with a desiccant packet for backup protection. If the lab’s cold storage gets crowded, storage errors become common. People stack bottles, open approaches to airflow, and let in humidity. That’s where small habits can ruin big projects.
Good storage practices aren’t rocket science. A dry, cool spot — usually a refrigerator — away from bright light makes the difference. Plenty of scientists get lazy about sealing things up. I use a screw-cap vial and toss in a fresh desiccant every time I break out a new batch. Label the container clearly, with date of opening and your initials. Others in the lab can spot problems and flag issues before it reaches your bench. Don’t leave NHS out in the open or in rooms with high humidity, like by the sink or near dishwashers.
Long-term storage brings another layer. If your project only calls for small amounts at a time, it’s smart to aliquot NHS into smaller vials to cut down how often the main container opens. This way, fewer temperature swings and less air contact reach the precious material. No fancy equipment needed — small amber vials, a steady hand, and basic discipline get results.
Cutting corners on chemical storage never pays off. N-Hydroxy Succinimide keeps its reliability only with a thoughtful approach. Invest a little effort in storage and labeling, and your experiments will deliver clean results. Simple, low-cost steps beat back waste and disappointment every time. Anyone serious about reproducible science has learned that by now.
N-Hydroxysuccinimide has earned respect for its role in making peptide bonds, crosslinking proteins, and all those fancy chemical reactions happening in pharmaceutical and biotech labs. Yet, as useful as NHS can be, I remember the first time I saw a colleague get a painful skin reaction after a powder spill—a sharp lesson in taking chemical safety way more seriously.
Dry NHS looks pretty tame sitting in its bottle. But start measuring or mixing, and the fine powder drifts everywhere. Skin contact leads to irritation; inhaling those particles is even riskier. Health and safety data point out that improper exposure can set off allergic or respiratory reactions. One research report in a chemical safety journal notes several cases where NHS exposure led to persistent dermatitis. Seeing someone deal with that makes you check your gloves more often.
The risks don’t stop at exposure—certain conditions push NHS into more dangerous territory. Heating it up, getting it wet, or allowing it to touch acids or bases means possible decomposition or hazardous byproducts. Stories from lab cleanups remind everyone that a simple overlooked spill becomes a bigger deal faster than you’d expect.
Work habits make the difference. At the bench, I learned early not to trust “it’ll be fine” thinking. Regular gloves help, but nitrile gloves last longer with NHS. Lab coats and splash goggles are basic, yet vital. I once failed to wear goggles for “just a quick transfer”—the close call with airborne powder in my face made that mistake unforgettable.
Fume hoods matter, especially for weighing or dissolving the solid. Airflow does way more than comfort; it means escaping particles get whisked away before reaching anyone’s lungs. I make it a point to check hood airflow and not leave the sash too high. Open bench work with NHS never gets my vote.
Storage habits speak to both safety and chemical stability. NHS keeps longer and safer cool and dry, away from acids, bases, and sources of ignition. Neatly labeled, tightly closed bottles keep confusion and accidents at bay. I’ve seen folks grab the wrong white powder for a reaction—clear labeling prevents those “how did this get in here?” moments.
Safety data sheets offer important info, but real understanding grows during hands-on training. Watching a supervisor demonstrate the transfer of NHS into a solvent, with each step explained—right down to careful scooping and waste disposal—left a mark. I repeat those steps every single time, checking the bench for residue and cleaning up right away.
Disposal stands as the last part. NHS waste finds its way into special labeled containers, never dumped down the drain or regular trash. This practice keeps the environment and handlers safe. Regulations require sticking to hazardous waste protocols; a missed step means more than a mess—it turns into a regulatory risk and health hazard.
Culture in a lab sets the tone for handling risks. Open conversation about near-misses or “almost accidents” lets newcomers learn from those who’ve been around chemicals like NHS for years. Reinforcing those habits—wearing all protective gear, slowing down transfers, tracking storage—means everyone goes home healthy. That priority matters more than any shortcut or fast experiment.
Anyone who’s prepared a reaction with N-hydroxisuccinimide (NHS) knows this chemical finds its way onto the bench for a reason. In my own research days sorting coupling reactions for protein labeling, one lesson stuck with me: never waste time trying to do the impossible with solubility. NHS keeps things simple. Its white, crystalline appearance tells one story, but how it mixes tells another.
Lab myths come and go, but the basics still come down to choosing solvents that work. NHS dissolves in water but not like sugar. Its hydrophilicity comes from its polar groups, so you’ll get some dissolution, but don’t expect it to totally vanish in a cold beaker of H2O. Some warm water with a bit of stirring helps. A standard buffer, mild temperature, and gentle agitation do more for NHS than fancy techniques or wishful thinking.
On the organic side, NHS prefers polar aprotic solvents—DMSO and DMF get it into solution without protest. Acetonitrile and acetone do a fair job, with methanol pulling some weight too. NHS stays away from non-polar ones like hexane or toluene, almost as if it refuses to get its shoes muddy. Years spent rotating through labs proved that point every time a rookie grabbed the wrong solvent.
Too many project delays start from ignoring the small stuff: simple solubility choices. In bioconjugation work, NHS esters rely on dissolving completely to react with amines. Unreacted NHS floating around wastes reagents and gives bad yields, which is just asking for another round of troubleshooting. Seeing that cloudy mix tells you right away that the plan needs changing.
Getting the solvent right also shapes much more than one experiment. In peptide synthesis and pharmaceutical manufacturing, poor solubility drags down production and purity. Industry leaders share these priorities, not just grad students in cramped labs. Losing valuable product due to improper solvent pairing costs both time and money. In this case, fact checks against established resources like PubChem and Merck Index always give NHS about 20 g/L solubility in water, with much more enthusiasm for DMF or DMSO.
While chemistry tools have advanced, plenty of training skips right over fundamental questions. Every so often, you see researchers fuss with NHS in odd combinations, hoping a miracle happens. Yet, basic chemistry—polar likes polar—hardly ever fails as a rule. Beyond that, everyone from lab supervisors to process engineers needs that comfort in routine. Consistently good results make for fewer surprises and smoother workdays.
From my own experience, the easiest fix often hides in clearer communication. Before opening that bottle of NHS, check not only the label but respected data sources. Pre-weigh needed amounts, bring all solvents to room temperature, and add NHS slowly, with patience. Use lab notebooks to record which solvent finally brought it into the fold, so others skip the guesswork.
More research moves faster when people trust simple rules. Choosing the right solvent brings measurable benefits in product yield, purity, and peace of mind. NHS isn’t a stubborn reagent—it just tells you what it wants if you pay attention.
N-Hydroxysuccinimide (often called NHS) has earned a steady place in research labs, both in universities and industry. Many researchers will recognize it from protein labeling, peptide synthesis, or making compounds light up in biological imaging. Chemists often jot “NHS” on bottles without giving much thought to its exact numbers, but the molecular weight really matters. For the record, NHS carries a molecular weight of 115.09 g/mol. Simple as it looks on the label, this number represents a lot more than a dusty fact from a college chemistry class.
Getting a reaction mix wrong eats up more time than most folks care to admit. If the person preparing a conjugation buffer misreads the NHS amount, the downstream effects pop up fast: weak signals, failed syntheses, and troubleshooting that can stretch for days. For anyone who’s poured hours into setting up an experiment, it’s frustrating to realize a simple calculation mistake based on wrong molecular weight wasted all that effort and budget. NHS plays a central role making esters that couple with amines, a bread-and-butter tool for labeling antibodies and proteins. Here, accuracy matters and a few extra milligrams can totally skew the expected results.
A molecule’s weight tells a chemist how much substance they need on the scale. NHS, built from four carbons, five hydrogens, three oxygens, and a nitrogen (C4H5NO3), totals 115.09 grams per mole. It’s not a fancy or elaborate molecule, but the need for accuracy remains the same as with larger, more complex chemicals. Prepare a batch for linking a fluorescent dye to a protein, and the math lines up every step of the way: moles converted from milligrams, stock solutions made to match.
Anyone who’s ever spent hours on a labeling protocol knows the sting of seeing faint bands on a gel after botching a mix. Too much NHS leads to wastage of expensive reactants; too little leaves half the target unlabeled. A smart calculator, coupled with careful conversion of weight to moles, prevents most headaches. Graduate students often talk about the “NHS trick,” which isn’t really a trick at all, but simple respect for reliable math and clean glassware.
Chemists trust reference sources from peer-reviewed publications, Material Safety Data Sheets (MSDS), and suppliers like Sigma-Aldrich for their numbers. Incorrect data can haunt a lab for years, so confirmation should always come from vetted resources. This prevents cascading errors and maintains reproducibility, an area badly bruised by vague methods and loose math.
Lab protocols often call for double checks—someone else peering over the numbers before starting a reaction. Some institutions promote digital calculators locked with official constants, including the molecular weight of NHS, to cut down on transcription errors. Teams who write clear protocols and mark relevant values on reagent bottles stand to dodge mistakes. Simple, concrete measures often solve problems more reliably than high-tech fixes.
Precise weights form the backbone of trustworthy science. Knowing the molecular weight of NHS allows labs to operate with efficiency, avoid burning time and supplies, and turn out data that stand up to peer scrutiny. Whether preparing routine mixes or pushing boundaries in biomedical research, attention to these details separates solid science from wasted effort.
| Names | |
| Preferred IUPAC name | 1-hydroxy-2,5-pyrrolidinedione |
| Other names |
NHS N-Hydroxysuccinimide N-Hidroxisuccinimida Succinimide, N-hydroxy- 1-Hydroxy-2,5-pyrrolidinedione |
| Pronunciation | /ɛn iː dʒaɪˈdrɒksi.sʌkˈsɪnɪmɪd/ |
| Identifiers | |
| CAS Number | 6066-82-6 |
| Beilstein Reference | 120696 |
| ChEBI | CHEBI:30946 |
| ChEMBL | CHEMBL12319 |
| ChemSpider | 10319 |
| DrugBank | DB03715 |
| ECHA InfoCard | 100.004.592 |
| EC Number | 213-426-9 |
| Gmelin Reference | 136116 |
| KEGG | C00417 |
| MeSH | D017350 |
| PubChem CID | 3609 |
| RTECS number | WH8575000 |
| UNII | 67VCF1Y1Y2 |
| UN number | 2811 |
| CompTox Dashboard (EPA) | DTXSID0041842 |
| Properties | |
| Chemical formula | C4H5NO3 |
| Molar mass | 115.09 g/mol |
| Appearance | White to off-white crystalline powder |
| Odor | Characteristic |
| Density | 1.437 g/cm3 |
| Solubility in water | soluble |
| log P | -1.37 |
| Vapor pressure | Negligible |
| Acidity (pKa) | 6.0 |
| Basicity (pKb) | 6.0 |
| Magnetic susceptibility (χ) | -51.5×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.470 |
| Viscosity | 1,920 mPa.s |
| Dipole moment | 4.52 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 206.3 J/(mol·K) |
| Std enthalpy of formation (ΔfH⦵298) | -222.9 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -887.1 kJ/mol |
| Pharmacology | |
| ATC code | D08AX |
| Hazards | |
| Main hazards | May cause respiratory irritation, skin irritation, and serious eye irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS07, GHS09 |
| Signal word | Warning |
| Hazard statements | H319: Causes serious eye irritation. |
| Precautionary statements | P264, P280, P305+P351+P338, P337+P313, P501 |
| NFPA 704 (fire diamond) | 2-1-0 |
| Flash point | 113.7 °C |
| Lethal dose or concentration | LD50 (rat, oral): 500 mg/kg |
| LD50 (median dose) | LD50 (median dose): 5000 mg/kg (rat, oral) |
| NIOSH | Not listed |
| PEL (Permissible) | PEL (Permissible) of N HIDROXISUCCINIMIDA: Not established |
| REL (Recommended) | 10 mg/m³ |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Succinic anhydride Succinimide N-Hydroxysulfosuccinimide |